It was shown that mutations that interest genes encoding epigenetic modifiers, mainly EZH2, ASXL1, SETBP1, BCOR, and IDH2, confer adverse prognoses in MDS [28,32]. Here, IDH2 is linked to myelodysplastic syndrome.